Thus, two different studies showed the induction of ROR1 (type 1 receptor tyrosine kinase-like orphan receptor) following treatment with trastuzumab emtansine [403] or chemotherapy [404]: ROR1 enhanced the expression of YAP/TAZ and the self-renewal of cancer stem cells, inducing therapeutic resistance. Here, ROR1 is linked to cancer.